Importance of immunotherapy in the treatment of recurrent cystitis
https://doi.org/10.21886/2308-6424-2021-9-1-87-94
Abstract
The review is devoted to the problems of diagnosis and treatment of chronic recurrent cystitis (CRC). The search was conducted using the Medline, PubMed, EMBASE databases. CRC is a common disease, especially among women of reproductive age. Human papillomaviruses (HPV) are part of the human virome and may be implicated in the development of CRC. Immunostimulating therapy is an effective alternative method for the treatment and prevention of CRC, notably in CRC of human papillomavirus aetiology.
About the Authors
Kh. S. Ibishev
Rostov State Medical University
Russian Federation
Competing Interests: no conflicts of interest
Russian Federation
Khalid S. Ibishev — M.D., Dr.Sc. (M), Assoc. Prof. (Docent); Prof., Dept. of Urology and Human Reproductive Health (with the Pediatric Urology and Andrology Course).
344022, Rostov-on-Don, 29 Nakhichevansky ln.; tel .: +7 (928) 777-77-14
Competing Interests: no conflicts of interest
D. V. Krakhotkin
Rostov State Medical University
Russian Federation
Competing Interests: no conflicts of interest
Russian Federation
Denis V. Krakhotkin — M.D., Urologist, Postgraduate student, Dept. of Urology and Human Reproductive Health (with Pediatric Urology and Andrology Course).
344022, Rostov-on-Don, 29 Nakhichevansky ln.
Competing Interests: no conflicts of interest
E. A. Mamedov
Rostov State Medical University
Russian Federation
Competing Interests: no conflicts of interest
Russian Federation
Eldar A. Mamedov — Resident, Dept. of Urology and Human Reproductive Health (with the Pediatric Urology and Andrology Course).
344022, Rostov-on-Don, 29 Nakhichevansky ln.
Competing Interests: no conflicts of interest
A. A. Mantsov
Rostov State Medical University
Russian Federation
Competing Interests: no conflicts of interest
Russian Federation
Artyom A. Mantsov — Student.
344022, Rostov-on-Don, 29 Nakhichevansky ln.
Competing Interests: no conflicts of interest
V. K. Mamedov
Rostov State Medical University
Russian Federation
Competing Interests: no conflicts of interest
Russian Federation
Vahid K. Mamedov — M.D., Urologist, Postgraduate student, Dept. of Urology and Human Reproductive Health (with Pediatric Urology and Andrology Course).
344022, Rostov-on-Don, 29 Nakhichevansky ln.
Competing Interests: no conflicts of interest
А. Kh. Ibisheva
E.P. Glinka Republican Children's Clinical Hospital
Russian Federation
Competing Interests: no conflicts of interest
Russian Federation
Aset Kh. Ibisheva – M.D.; Allergist-Immunologist.
366041, Chechen Republic, Grozny, 1011.I. Bisultanova st.
Competing Interests: no conflicts of interest
References
1. Viliukha A., Antonova O. Uncomplicated recurrent urinary tract infection: treatment and prophylaxis. Reproductive health. Eastern Europe. 2016;6(2):250-257. (In Russ.). eLIBRARY ID:25732808
2. Gadzhieva Z.K., Kazilov Yu.B. The features in preventing recurrent lower urinary tract infection. Urology. 2016;(3):65-76. (In Russ.). eLIBRARY ID: 26436155
3. Ibishev K.S. Modern view on treatment and prophylaxis of relapsing lower urinary tract infection. Effektivnaya far-makoterapiya. 2015;(26):28-30. (In Russ.). eLIBRARY ID: 23850639
4. Lee PJ, Kuo HC. High incidence of lower urinary tract dysfunction in women with recurrent urinary tract infections. Low Urin Tract Symptoms. 2020;12(1):33-40. DOI 10.1111/luts.12280.
5. Ibishev H.S., Krakhotkin D.A., Vasiliev A.A., Krayniy P.A. Viral etiology of recurrent urinary tract infections. Urology Herald. 2017;5(1):26-31. (In Russ.). DOI: 10.21886/2308-6424-2017-5-1-26-31
6. Kuz'min I.V., Slesarevskaya M.N., Al-Shukri S.H. D-man-nose for prevention and treatment of lower urinary tract infection: pathogenetic basics and clinical results. Urolo-giia. 2020;(4):131-138. (In Russ.). DOI: 10.18565/urol-ogy.2020.4.131-138
7. Perepanova T.S., Volkova E.M. Apropos of pathogenesis of recurrent lower urinary tract infections. Experimental & clinical urology. 2015;(3):100-105. (In Russ.). eLIBRARY ID: 25622736
8. Jhang JF, Hsu YH, Peng CW, Jiang YH, Ho HC, Kuo HC. Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome. J Urol. 2018;200(3):590-596. DOI 10.1016/j.juro.2018.03.133.
9. Robles MTS, Cantalupo PG, Duray AM, Freeland M, Murkows-ki M, van Bokhoven A, Stephens-Shields AJ, Pipas JM, Impe-riale MJ. Analysis of viruses present in urine from patients with interstitial cystitis. Virus Genes. 2020;56(4):430-438. DOI 10.1007/s11262-020-01767-z.
10. Shigehara K, Sasagawa T, Namiki M. Human papillomavirus infection and pathogenesis in urothelial cells: a mini-review. J Infect Chemother. 2014;20(12):741-7. DOI 10.1016/j.jiac.2014.08.033.
11. Mumm JN, Osterman A, Ruzicka M, Stihl C, Vilsmaier T, Munker D, Khatamzas E, Giessen-Jung C, Stief C, Staehler M, Rodler S. Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur Urol. 2020;78(4):624-628. DOI 10.1016/j.euru-ro.2020.05.013.
12. Hsu CY, Lin CL, Kao CH. Association between Chronic Interstitial Cystitis and Herpes Zoster. Int J Environ Res Public Health. 2020;17(7):2228. DOI 10.3390/ijerph17072228.
13. Ibishev K.S., Lapteva T.O., Krachotkin D.V., Ryabenchenko N.N. The role of viral infection in the development of recurrent lower urinary tract infections. Urologiia. 2019;(5):134-137. (In Russ.). DOI 10.18565/urology.2019.5.136-139.
14. Khismatullina Z.R., Mustafina G.R., Teregulova G.A., Malikova Yu.O., Tsink S.S. Allokin-alpha application in combination treatment for papilloma-associated lesions of anogenital region in female patients. Medicinskij vestnik Bashkortostana. 2011;6(3):111-114. (In Russ.). eLIBRARY ID: 17047867
15. Wade D, Cooper J, Derry F, Taylor J. Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study. Trials. 2019;20(1):223. doi 10.1186/s13063-019-3275-x.
16. Perepanova T.S., SHevelev A.N., Soroka I.V., Dunec K.A., Go-relysheva N.E. Klinicheskaya effektivnost' interferonoterapii v sostave kompleksnogo lecheniya hronicheskogo cistita. Russkijmedicinskijzhurnal. 2012;20(36):1723. (In Russ.). eLIBRARY ID:18763212
17. Derevyanko T.I., Ryzhkova E.V., Tolchanov S.A. Primenenie preparata Polioksidonij pri lechenii zhenshchin s hroniches-kimi infekcionno-vospalitel'nymi zabolevaniyami nizhnih otdelov mochevyh putej. Effektivnaya farmakoterapiya. 2012;(40):12-15. (In Russ.). eLIBRARY ID: 21955899
18. Dikke G.B., Ostromensky V.V. Immunomodulators use in a treatment of lower urogenital tract infections in women. Ginecology. 2019;21(1):69-74. (In Russ.). DOI: 10.26442/20795696.2019.1.190220
19. Kondrat'eva Iu.S., NeTmark A.I., Zheltikova Ia.D. Efficiency of combination therapy for chronic recurrent cystitis in women with urogenital infections. Russian bulletin of obstetrician-gynecologist. 2014;14(6):94-99. (In Russ.). eLIBRARY ID: 23060912
20. Ibishev Kh.S. Some aspects of the treatment of persistent lower urinary tract infections in women. Urologiia. 2012;(5):30-34.
21. Milovanov A.P., Malinovskaya V.V., Vyzhlova E.N., Zarochentseva N.V., Keshchyan L.V., Fokina TV., Mikaelyan A.V. Anti-inflammatory effect of domestic medicinal preparation viferon® in chronic papillomavirus infection of pregnant women according morphometry of placenta. Clinical and experimental morphology. 2017;2:28-33. (In Russ.). eLIBRARY ID: 29946263
22. Ibishev H.S. Celesoobraznost’ interferonoterapii pri recidiviruyushchej infekcii nizhnih mochevyh putej. Lechashchij vrach. 2012;10:88. (In Russ.). eLIBRARY ID:21786054
23. Rakitianskaya I.A., Riabova T.S., Todzhibaev U.A., Kalashnikova A.A. Allokin-alpha - new approaches in the treatment of chronic virus Epstein-Barr infections. Problems of Virology. 2019;64(3):118-124. (In Russ.). DOI: 10.18821/0507-4088-2019-64-3-118-124
24. Ibishev Kh.S., Krainiy P.A., Magomedov R.G., Ulitina I.V., Evstafyeva N.A., Gusova Z.R., Ilyash A.V. Immunological aspects of the pathogenesis of chronic recurrent bacterial prostatitis. Cytokines and inflammation. 2017;16(3):24-29. (In Russ.). eLIBRARY ID: 32844310
25. Akimov O.V., Kostrameyev S.A., Dyshkovets A.A. Experience of use of allokin-alfa in the treatment of infectious-inflammatory diseases of the genitourinary system complicated by excretory-toxic infertility. Urologiia. 2013;(1):48-53. (In Russ.). eLIBRARY ID: 18808799
26. Gajdukov S.N., Petryaeva M.A., Klyus O.S., Komissarova O.N. Rol’ Allokina-al’fa v kompleksnom lechenii papillomavirusnyh porazhenij shejki matki. TERRA MEDICA NOVA. 2007;2(46):44-46. (In Russ.). eLIBRARY ID: 16370660
Review
For citations:
Ibishev Kh.S., Krakhotkin D.V., Mamedov E.A., Mantsov A.A., Mamedov V.K., Ibisheva А.Kh. Importance of immunotherapy in the treatment of recurrent cystitis. Urology Herald. 2021;9(1):87-94. (In Russ.) https://doi.org/10.21886/2308-6424-2021-9-1-87-94
Views:
7913
Email this article 
